Young-Soon Jang

Title: Young-Soon Jang: Innovator in Anti-Inflammatory and Cancer Research

Introduction

Young-Soon Jang is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the fields of anti-inflammatory compositions and cancer diagnostics. With a total of 2 patents, her work is recognized for its potential impact on medical science.

Latest Patents

One of her latest patents is focused on CD93 or the use of its soluble fragment. This invention relates to an anti-inflammatory composition that utilizes an antibody specifically binding to CD93 or its soluble fragment. Additionally, it includes a diagnostic method and a diagnostic kit for inflammatory diseases using the specific antibody or aptamer related to CD93. Another notable patent is the TMPRSS4-specific human antibody. This invention pertains to a transmembrane protease, serine (TMPRSS4)-specific human antibody. It includes a complementarity determining region (CDR) and a framework region (FR) derived from a human antibody that specifically binds to TMPRSS4. The TMPRSS4-specific human antibody can be utilized in the diagnosis of cancer, disease classification, visualization, treatment, and prognostic evaluation.

Career Highlights

Young-Soon Jang is affiliated with the Korea Research Institute of Bioscience and Biotechnology. Her work at this esteemed institution has allowed her to focus on groundbreaking research that addresses critical health issues.

Collaborations

Some of her notable coworkers include Young Woo Park and Jae Won Jeon. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Young-Soon Jang's innovative work in anti-inflammatory and cancer research highlights her significant role in advancing medical science. Her patents reflect her dedication to improving diagnostic and therapeutic methods.